ArticlePloS one2025

A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting.

Renxian Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.